Helix Acquisition (HLXA) Stock Price, News & Analysis

Company Overview

As of April 5, 2022, Helix Acquisition Corp. was acquired by MoonLake Immunotherapeutics AG, in a reverse merger transaction. Helix Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses or entities. The company was founded in 2020 and is based in Boston, Massachusetts.

Key Stats

• Today's Range: N/A
• 50-Day Range: $7.05 to $10.05
• 52-Week Range: N/A
• Volume: 554,000 shs
• Average Volume: 89,000 shs
• Market Capitalization: $158.07 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

HLXA Stock Analysis - Frequently Asked Questions

When did Helix Acquisition IPO?

Helix Acquisition (HLXA) raised $100 million in an initial public offering (IPO) on Tuesday, October 20th 2020. The company issued 10,000,000 shares at $10.00 per share. Jefferies served as the underwriter for the IPO.

What other stocks do shareholders of Helix Acquisition own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Helix Acquisition investors own include Applied Therapeutics (APLT), Churchill Capital Corp IV (CCIV), Gores Holdings IV (GHIV), Lottery.com (LTRY), Nascent Biotech (NBIO), Qell Acquisition (QELLU) and Vector Group (VGR).

Company Calendar

• Today: 7/02/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: Shell Companies
• Sub-Industry: N/A
• Current Symbol: NASDAQ:HLXA
• CIK: 1821586
• Web: N/A
• Phone: 857 702 0370
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 11,930,000
• Free Float: N/A
• Market Cap: $158.07 million
• Optionable: Not Optionable
• Beta: 0.12